• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIO-TECHNOLOGY GENERAL (ISRAEL) LTD. EUFLEXXA; 1% SODIUM HYALURONATE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIO-TECHNOLOGY GENERAL (ISRAEL) LTD. EUFLEXXA; 1% SODIUM HYALURONATE Back to Search Results
Catalog Number 6301182010
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fall (1848); Bone Fracture(s) (1870)
Event Date 12/20/2019
Event Type  Injury  
Event Description
Lost balance [balance disorder].Had fallen and broken her arm [fall].Had fallen and broken her arm [upper limb fracture] case (b)(4) is a serious spontaneous case received from a non-health professional via regulatory authority in united states.This report concerns a female of an unknown age who had lost balance, had fallen and broken her arm during treatment with intra-articular euflexxa (sodium hyaluronate) solution for injection 10 mg, unknown dose, route and frequency, for an unknown indication from an unknown start date to an unknown stop date.The patient had lost balance, had fallen and broken her arm.The patient was hospitalized on an unknown date due to lost balance, had fallen and broken her arm.Action taken with euflexxa was unknown.At the time of this report, the outcome of lost balance, had fallen and broken her arm was unknown no concomitant medication was reported.All events in the case were reported as serious.At the time of reporting the case outcome was unknown.Ferring's sender comment: association of euflexxa to lost balance, fall, and broken her arm events are considered unrelated due to lack of biological plausibility.Overall listedness (core label) is unlisted.Reporter causality: related company causality: not related other case numbers: internal # - others = mw5092963 this ae occurred in the us and concerns the medical device euflexxa.Please report to your local health authority if required by local law.This ae is not reportable in eu because it did not occur in a eu + efta country and did not result in a corrective action by the manufacturer no corrective action was done by the manufacturer or requested by regulators.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EUFLEXXA
Type of Device
1% SODIUM HYALURONATE
Manufacturer (Section D)
BIO-TECHNOLOGY GENERAL (ISRAEL) LTD.
be'er tuvia industrial zone
pob 571
kiryat malachi, 83104
IS  83104
Manufacturer (Section G)
BIO-TECHNOLOGY GENERAL (ISRAEL) LTD.
be'er tuvia industrial zone
pob 571
kiryat malachi, 83104
IS   83104
Manufacturer Contact
100 interpace parkway
parsippany, nj 
3044828
MDR Report Key9836776
MDR Text Key183653128
Report Number3000164186-2020-00006
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other
Type of Report Initial
Report Date 03/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/16/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Catalogue Number6301182010
Device Lot NumberL14134A
Was Device Available for Evaluation? No
Date Manufacturer Received03/03/2020
Is the Device Single Use? Yes
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-